Skip to content
Tuesday, August 9, 2022
Latest:
  • Genome-wide study reveals new susceptibility genetic variants for lung cancer
  • Don’t get into a tizzy if your water is fizzy
  • The path forward: a more inclusive healthcare system
  • Raising awareness of spina bifida
  • Fertility Series: Advanced maternal age

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

BRCA

dna-1903318_1280
Policywise 

Direct-to-consumer BRCA testing: Can a reasonable decision still require caution?

March 21, 2018March 21, 201823andMe, BRCA, genetic testing, health policy, Mary Anderlik Majumder, US FDA

On March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1

Read more

From the Labs Video of the Month

From The Labs Image of the Month From the Labs: A beating developing mouse heart.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951